MYD88 Antibodies, cDNA Clones Research Reagents

MYD88 (MYD88 Innate Immune Signal Transduction Adaptor, also known as IMD68; MYD88D), located on 3p22.2, is a Protein Coding gene. This gene encodes a cytosolic adapter protein that plays a central role in the innate and adaptive immune response. MYD88 is a key downstream adaptor for most Toll-like receptors (TLRs) and interleukin-1 receptors (IL1Rs), and functions as an essential signal transducer in the interleukin-1 and Toll-like receptor signaling pathways. MYD88 shares 81% amino acid identity with murine MyD88.

MYD88 Antibody (3)

    MYD88 cDNA Clone (18)


    In expression vector


    In expression vector

    MYD88 qPCR Primer (1)

    More Product Popular With Customers

    MYD88 Background

    Myeloid differentiation primary response protein 88 (MyD88) is a critical adaptor protein involved in Toll-like receptor (TLR) and interleukin-1 (IL-1) receptor family signaling controlling innate immune responses and inflammation. MyD88 links IL-1 receptor (IL-1R) or TLR family members to IL-1R-associated kinase (IRAK) family kinases via homotypic protein-protein interaction. Activation of IRAK family kinases leads to a variety of functional outputs, including the activation of nuclear factor-kappa B (NFκB), mitogen-activated protein kinases, and activator protein 1, making MyD88 a central node of inflammatory pathways. Genetic deletion of MyD88 function results in profound suppression of inflammation and reduced resistance of the host to pathogens indicating non-redundant roles of MyD88. Detection of MyD88 expression was to predict the prognosis of various human cancers, e.g., lymphoid, liver, and colorectal cancers.

    MYD88 References

    • Wang L, et al. (2018) Dual functional roles of the myd88 signaling in colorectal cancer development. Biomed Pharmacother 107 177-184.
    • Gallot YS, et al. (2018) Myd88 is required for satellite cell-mediated myofiber regeneration in dystrophin-deficient mdx mice. Hum Mol Genet 27 (19): 3449-3463.
    • Di Padova F, et al. (2018) Myd88 as a therapeutic target for inflammatory lung diseases. Expert Opin Ther Targets 22 (5): 401-408.
    • Deguine J, et al. (2014) Myd88: A central player in innate immune signaling. F1000Prime Rep 6 97.

    Note: Flag® is a registered trademark of Sigma Aldrich Biotechnology LP. It is used here for informational purposes only.